GfK – Factors Supporting a Sustainable European Biosimilar Medicines Market

A study about the future sustainability of the biosimilar medicines market undertaken by GfK Market Access on behalf of the European Biosimilars Group, now the Biosimilar Medicines Group.

picto-project

Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
Biosimilars Market Review 2023 18 September 2023 The purpose of this Market Review is to provide a…
The European Commission needs to prioritise equitable access… 25 January 2022 Over 15 years ago, the world’s first biosimilar was launched.…
Market review Generic medicines policy 2023 - Policy… 29 June 2023 The Generic Market Access Committee (Generic medicines Group, a Medicines…

GfK – Factors Supporting a Sustainable European Biosimilar Medicines Market

Related Posts

Share on Mastodon